arrow
A

Alexander Hammers

kings college london
H指数:67
被引数:2.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dosimetry and immunohistochemistry study to establish radiolabelled prostate-specific membrane antigen (PSMA) as a potential theranostic target in high-grade glioma treatment

剂量测定和免疫组化研究以建立放射性标记的前列腺特异性膜抗原(PSMA)作为高级别胶质瘤治疗中潜在的治疗诊断靶点

2026-08-210
OA
Does a monoclonal antibody targeting immune cells affect glutamatergic level in schizophrenia? A multimodal PET/MRS brain imaging study

靶向免疫细胞的单克隆抗体是否影响精神分裂症中的谷氨酸能水平?一项多模态PET/MRS脑成像研究

2026-07-090
OA
The Dementias Platform UK PET/MR harmonisation and test-retest study: assessment of PET repeatability and reproducibility across the national network

英国痴呆平台PET/MR标准化与测试-再测试研究:对全国网络中PET可重复性和可再现性的评估

2026-04-290
OAAI
Inter-individual variability of neurotransmitter receptor and transporter density in the human brain
2026-01-130
OAAI
Immune alterations in schizophrenia and the effects of a therapeutic antibody: a neuroimaging study

精神分裂症中的免疫改变及一种治疗性抗体的影响:一项神经影像学研究

Brain
IF11.7
2025-12-010
OA
Disorder of consciousness rather than complete Locked-In Syndrome for end stage Amyotrophic Lateral Sclerosis: a case series

意识障碍而非完全性闭锁综合征用于终末期肌萎缩侧索硬化症:一个病例系列

2025-11-190
OAAI
Left ventricular geometry, brain architecture, and cognition: an observational study

左心室几何形态、大脑结构和认知:一项观察性研究

2025-10-011
PRE
TARGETING MICROGLIAL ACTIVATION IN SCHIZOPHRENIA: A LONGITUDINAL [18F]DPA-714 PET IMAGING STUDY INVESTIGATING THE EFFECTS OF A 3-MONTH TREATMENT WITH NATALIZUMAB
2025-08-010
OA